Lv2
200 积分 2021-12-01 加入
Acute treatment of migraine in children and adolescents: review of the American Academy of Neurology Practice guideline update
3天前
求助中
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
21天前
已完结
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
21天前
已完结
Most bothersome symptoms in patients with migraine: A hospital-based study in Taiwan
1个月前
已完结
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
1个月前
已完结
Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75-mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo-Controlled Trial
1个月前
已完结
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants
1个月前
已完结
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
3个月前
已完结
Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study
3个月前
已完结
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
3个月前
已完结
皖公网安备34019202002308
